Tablets - 5 mg
Glibenklamid is an oral hypoglycemiant, derivative of the sulfonylurea. The decrease of blood glucose concentration happens because of the stimulation of insulin secretion by the pancreas. This action needs the presence of the beta functional cells.
Glibenklamid is indicated in diabetes mellitus type II (non - insulin dependent diabetes).
Oral drops solution – (10.000 UI + 10.000 UI) / ml
Sugar-coated tablets – 10 mg
Film-coated tablets – 400 mg
Film-coated tablets – 600 mg
Solution for injection - (0.1%) 1 mg/1 ml
